Clinical Trial

Effective Phaco Time and Endothelial Cell Loss When Using Veritas

Recruiting
View on ClinicalTrials.gov →
Summary
This study is a single center, prospective study of cumulative dissipated energy and endothelial cells loss per phacoemulsification procedure after successful cataract surgery. Subjects will be assessed 3 months postoperatively at a single visit. Clinical evaluations will include central corneal thickness, specular microscopy, as well as measurement of visual acuities at distance.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-09.
Status change: Not Yet Recruiting → Recruiting 2025-10-07
Trial Details
NCT Number NCT07176416
Lead Sponsor Aloha Vision Consultants
Collaborators: Sengi
Conditions Cataract
Enrollment 50 participants
Start Date 2025-10-03
Primary Completion 2026-10-01 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-10-09